Astragalus Polysaccharide Modulates the Gut Microbiota and Metabolites of Patients with Type 2 Diabetes in an In Vitro Fermentation Model

Xin Zhang,Lina Jia,Qian Ma,Xiaoyuan Zhang,Mian Chen,Fei Liu,Tongcun Zhang,Weiguo Jia,Liying Zhu,Wei Qi,Nan Wang
DOI: https://doi.org/10.3390/nu16111698
IF: 5.9
2024-05-30
Nutrients
Abstract:This study investigated the effect of astragalus polysaccharide (APS, an ingredient with hypoglycemic function in a traditional Chinese herbal medicine) on gut microbiota and metabolites of type 2 diabetes mellitus (T2DM) patients using a simulated fermentation model in vitro. The main components of APS were isolated, purified, and structure characterized. APS fermentation was found to increase the abundance of Lactobacillus and Bifidobacterium and decrease the Escherichia-Shigella level in the fecal microbiota of T2DM patients. Apart from increasing propionic acid, APS also caused an increase in all-trans-retinoic acid and thiamine (both have antioxidant properties), with their enrichment in the KEGG pathway associated with thiamine metabolism, etc. Notably, APS could also enhance fecal antioxidant properties. Correlation analysis confirmed a significant positive correlation of Lactobacillus with thiamine and DPPH-clearance rate, suggesting the antioxidant activity of APS was related to its ability to enrich some specific bacteria and upregulate their metabolites.
nutrition & dietetics
What problem does this paper attempt to address?
The paper aims to study the effects of Astragalus polysaccharides (APS) on the gut microbiota and metabolites of patients with type 2 diabetes mellitus (T2DM). Specifically, the study explores how APS regulates the gut microbial community structure and its metabolites in T2DM patients through an in vitro fermentation model. The main findings include: 1. **Microbial Community Changes**: - APS fermentation increased the abundance of Lactobacillus and Bifidobacterium in the fecal microbiota of T2DM patients, while reducing the levels of Escherichia-Shigella. - At the genus level, compared to the healthy control group, the T2DM group had a higher relative abundance of Enterobacteriaceae and Escherichia-Shigella; however, after the addition of APS, the relative abundance of these harmful bacteria decreased, and the relative abundance of beneficial bacteria such as Lactobacillus and Bifidobacterium increased. 2. **Metabolite Changes**: - APS not only increased the levels of propionic acid but also elevated the content of all-trans-retinoic acid and thiamine, which have antioxidant properties. - Correlation analysis showed a significant positive correlation between Lactobacillus and thiamine and DPPH scavenging rate, indicating that the antioxidant activity of APS is related to its enrichment of certain specific bacteria and the upregulation of their metabolites. In summary, this study aims to reveal the specific regulatory effects of APS on the gut microbiota and metabolites of T2DM patients through an in vitro fermentation model and to explore its potential therapeutic mechanisms.